cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 1.6% – Should You Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s stock price dropped 1.6% during trading on Thursday. The stock traded as low as $0.3622 and last traded at $0.3728. Approximately 74,629 shares changed hands during mid-day trading, a decline of 16% from the average daily volume of 89,154 shares. The stock had previously closed at $0.3789.

Wall Street Analyst Weigh In

Separately, Maxim Group downgraded cbdMD from a “buy” rating to a “hold” rating in a research note on Monday, August 17th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

cbdMD Stock Performance

The firm has a 50-day moving average price of $0.45 and a 200-day moving average price of $0.62.

cbdMD (NYSEAMERICAN:YCBD) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.08). The firm had revenue of $5.55 million during the quarter, compared to the consensus estimate of $5.69 million. cbdMD had a negative return on equity of 34.26% and a negative net margin of 13.80%.

cbdMD Company Profile

cbdMD, Inc (NYSE American: YCBD) is a consumer health and wellness company that develops, markets and sells hemp-derived cannabinoid products. Its offerings have included cannabidiol (CBD) oils and tinctures, gummies and other ingestible products, capsules, creams and lotions, as well as products formulated for sleep, recovery and general wellness.

The company also markets CBD products for pets and has expanded its portfolio to include additional cannabinoid-based and functional wellness products.